Functional aging in health and heart failure: the COmPLETE Study

Jonathan Wagner1, Raphael Knaier1, Denis Infanger1

  • 1Department of Sport, Exercise and Health, University of Basel, Birsstrasse 320 B, 4052, Basel, Switzerland.

Insights

This study identifies key physical fitness and cardiovascular biomarkers for healthy aging and heart failure. Findings will guide diagnostic recommendations for optimizing healthspan and preventing cardiovascular disease.

Area of Science:

  • Gerontology and Cardiovascular Medicine
  • Biomarker Discovery
  • Aging Research

Background:

  • Cardiovascular diseases, including heart failure, are leading causes of morbidity, with aging as a primary risk factor.
  • Age-related decline in physical fitness and organ function significantly impacts healthspan.
  • Identifying biomarkers to differentiate healthy aging from heart failure-related dysfunction is crucial.

Purpose of the Study:

  • To identify physical fitness and cardiovascular biomarkers that best reflect age-related cardiovascular risk.
  • To determine which physical fitness markers are most impaired in heart failure patients.
  • To inform diagnostic guidance and prevention strategies for optimizing healthspan.

Main Methods:

  • A cross-sectional study with two cohorts: COmPLETE-Health (healthy aging, n=490) and COmPLETE-Heart (heart failure, n=80).
  • Comprehensive assessment of physical fitness (cardiorespiratory fitness, walking speed, balance, strength) and cardiovascular function (pulse wave velocity, endothelial function, arterial structure).
  • Objective assessment of physical activity via accelerometry and calculation of 'health distances' using statistical methods.

Main Results:

  • The study aims to identify specific biomarkers distinguishing healthy aging from heart failure.
  • It will pinpoint physical fitness components most affected by heart failure.
  • The research will establish quantitative measures of 'health distance' for comparative analysis.

Conclusions:

  • This research will provide a comprehensive understanding of aging-related cardiovascular changes.
  • It is expected to define new diagnostic recommendations for aging populations.
  • The findings will guide targeted interventions for primary and secondary prevention to enhance healthspan.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
227